Featured Publications
The knowns and unknowns of treatment for alcoholic hepatitis
Sehrawat T, Liu M, Shah V. The knowns and unknowns of treatment for alcoholic hepatitis. The Lancet Gastroenterology & Hepatology 2020, 5: 494-506. PMID: 32277902, PMCID: PMC7238289, DOI: 10.1016/s2468-1253(19)30326-7.Peer-Reviewed Original ResearchConceptsAlcoholic hepatitisLiver diseaseSevere alcoholic hepatitisInflammatory liver diseaseChronic liver diseaseOngoing clinical trialsEffective medical treatmentMedical therapyHigh morbidityClinical trialsHepatitisPreclinical studiesNew therapiesRapid onsetMedical treatmentMyriad complicationsEffective therapeuticsModest effectivenessAlcohol dependencySeries paperPatientsTherapyDiseaseTreatmentLong term
2022
THU033 Improving NIAAA criteria for the diagnosis of alcoholic hepatitis, role of systemic inflammation
Pose E, Avitabile E, Díaz A, Montironi C, Perez M, Gratacós-Gines J, Evole H, Sehrawat T, Malhi H, Olivas P, Hernandez-Gea V, Shah V, Kamath P, Ginès P. THU033 Improving NIAAA criteria for the diagnosis of alcoholic hepatitis, role of systemic inflammation. Journal Of Hepatology 2022, 77: s136-s137. DOI: 10.1016/s0168-8278(22)00653-5.Peer-Reviewed Original Research
2019
462 – Circulating Extracellular Vesicles and Sphingolipids Cargo are Highly Accurate Novel Biomarkers for Diagnosis of Alcoholic Hepatitis
Sehrawat T, Arab J, Simonetto D, Sanyal A, Chalasani N, Gores G, Kamath P, Shah V, Malhi H. 462 – Circulating Extracellular Vesicles and Sphingolipids Cargo are Highly Accurate Novel Biomarkers for Diagnosis of Alcoholic Hepatitis. Gastroenterology 2019, 156: s-98. DOI: 10.1016/s0016-5085(19)37035-0.Peer-Reviewed Original Research